B

BRT Blood Reprogramming Technologies Lda

1 employees

BRT develops direct cell reprogramming technologies to generate autologous blood products for regenerative medicine.

Basic info

biotechnology research

Research and Development

Biotechnology

Direct Reprogramming

Health Care

Cancer Treatment

Medical

Blood Reconstitution

Hematopoietic Stem Cells

2017